Hydroxychloroquine-induced erythroderma

Indian Journal of Pharmacology

Volumn 49, Issue 1, 2017, Pages 132-134

  Pai, Sunil B ^a   Sudershan, Bhuvaneshwari ^a   Kuruvilla, Maria ^a   Kamath, Ashwin ^a   Suresh, Pooja K ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Erythroderma; hydroxychloroquine; systemic lupus erythematosus

Indexed keywords

ANTIHISTAMINIC AGENT; CALAMINE; EMOLLIENT AGENT; FLUTICASONE; HYDROXYCHLOROQUINE; HYDROXYZINE; LIQUID PARAFFIN; METHOTREXATE; PREDNISOLONE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG INDUCED ERYTHRODERMA; DRUG POTENCY; DRUG WITHDRAWAL; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MIDDLE AGED; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOPSY; CHEMICALLY INDUCED; DRUG ERUPTION; PATHOLOGY;

ANTIRHEUMATIC AGENTS; BIOPSY; DERMATITIS, EXFOLIATIVE; DRUG ERUPTIONS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 85014549472     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.201027     Document Type: Article

References (10)

1. Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 1997;36:799-805
2. Grant-Kels JM, Fedeles F, Rothe MJ. Exfoliative dermatitis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's Dermatology in General Medicine. 8th ed. New York: McGraw Hill; 2008. p. 266-79
3. World Health Organization. The Use of the WHO-UMC System for Standardised Case Causality Assessment. Available from: http://www.who-umc.org/Graphics/24734.pdf. [Last cited on 2015 Oct 02]
4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45
5. Marzano AV, Borghi A, Cugno M. Adverse drug reactions and organ damage: The skin. Eur J Intern Med 2016;28:17-24
6. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: A clinical study of 97 cases. BMC Dermatol 2005;5:5
7. César A, Cruz M, Mota A, Azevedo F. Erythroderma. A clinical and etiological study of 103 patients. J Dermatol Case Rep 2016;10:1-9
8. Hulmani M, Nandakishore B, Bhat MR, Sukumar D, Martis J, Kamath G, et al. Clinico-etiological study of 30 erythroderma cases from tertiary center in South India. Indian Dermatol Online J 2014;5:25-9
9. Slagel GA, James WD. Plaquenil-induced erythroderma. J Am Acad Dermatol 1985;12 (5 Pt 1):857-62
10. Pelle MT, Callen JP. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002;138:1231-3.